Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Neoplasm Metastasis × Arsenic Trioxide × Clear all

Phase

Status

Unknown 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasm Metastasis 1 Leukemia, Promyelocytic, Acute 1 Leukemia 1

Interventions

trastuzumab deruxtecan 4 Cisplatin 4 toripalimab 3 pembrolizumab 3 Radiosurgery 3 Bevacizumab 3 sacituzumab govitecan 2 cemiplimab 2 Therapeutics 2 Standard of Care 2 Radiotherapy 2 Palliative Care 2 Injections 2 Gemcitabine 2 Fulvestrant 2 Fluorouracil 2 Cyclophosphamide 2 Carboplatin 2 130-nm albumin-bound paclitaxel 2 zimberelimab 1 vedolizumab 1 tislelizumab 1 sintilimab 1 lobaplatin 1 ivosidenib 1 irinotecan sucrosofate 1 fludarabine 1 exemestane 1 eribulin 1 enzalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07348107 2026-01-16

ATARI-PDAC

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 1 Not yet recruiting

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡